Bajaj Healthcare Ltd.

View in App
328.45 -5.60 ▼-1.7%

25 April 2024, 04:03:38 PM
Volume: 135,820

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.bajajhealth.com
Market Cap 909.37 Cr.
Enterprise Value(EV) 1,255.14 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 7.71 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 42.76 Trailing Twelve Months Ending 2023-12
Industry PE 41.74 Trailing Twelve Months Ending 2023-12
Book Value / Share 116.55 Trailing Twelve Months Ending 2023-12
Price to Book Value 2.83 Calculated using Price: 329.50
Dividend Yield 0.30 Period Ending 2023-03
No. of Shares Subscribed 2.76 Cr. 27,598,400 Shares
FaceValue 5
About Bajaj Healthcare Ltd.
Bajaj Healthcare is a pharmaceutical company with manufacturing and marketing capabilities in Active Pharmaceutical Ingredients (APIs), Intermediates and Finished Dosage Formulations (FDFs) with focus on Vitamins, Amino Acids, Anti-Convulsants and Finished Dosage Forms (FDFs) caters to various therapeutic segments.

Bajaj Healthcare Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Bajaj Healthcare Ltd. Performance

View details >>
1 Day
-1.68%
1 Week
+4.04%
1 Month
+8.24%
3 Month
-1.41%
6 Month
-16.65%
1 Year
+1.96%
2 Year
-5.30%
5 Year
10 Year

Bajaj Healthcare Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 22.38 19.6 10.77 17.68 20.18 18.92 38.09 24.33 12.36
Return on Capital Employed (%) 19.16 18 14.52 18.25 19.75 19.47 35.91 20 11.88
Return on Assets (%) 4.5 4.12 3.65 6.23 6.1 8.28 19.14 11.45 5.3

Bajaj Healthcare Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 82 89 99 114 129 178 258 328 368 316
Non Curr. Liab. 22 32 28 23 20 27 85 71 98 59
Curr. Liab. 85 88 93 131 117 138 183 322 436 461
Minority Int.
Equity & Liab. 189 209 219 268 267 343 526 721 901 836
Non Curr. Assets 110 131 128 129 130 175 267 323 392 268
Curr. Assets 79 78 91 140 137 168 258 398 510 568
Misc. Exp. not W/O
Total Assets 189 209 219 268 267 343 526 721 901 836

Bajaj Healthcare Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 197 200 207 290 325 410 657 680 673 498
Other Income 0 0 2 2 1 7 7 1 2 3
Total Income 197 201 210 292 326 417 664 681 675 501
Total Expenditure -168 -170 -176 -250 -282 -362 -521 -561 -566 -419
PBIDT 29 30 33 42 44 55 143 120 109 82
Interest -8 -8 -8 -8 -8 -7 -8 -13 -23 -31
Depreciation -9 -9 -11 -11 -11 -12 -16 -18 -27 -28
Taxation -5 -5 -6 -8 -8 -11 -36 -18 -15 -2
Exceptional Items
PAT 8 8 8 15 16 25 83 71 43 21
Adjusted EPS 3 3 3 6 6 9 30 26 16 8

Bajaj Healthcare Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 17 28 25 22 17 25 21 44 1 -22
Cash Fr. Inv. -9 -17 -31 -8 -12 -13 -28 -109 -75 -93
Cash Fr. Finan. -8 -11 5 -13 2 -13 3 75 62 132
Net Change 1 0 0 0 7 0 -4 10 -12 16
Cash & Cash Eqvt 1 1 0 1 8 8 4 14 2 18

Bajaj Healthcare Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 67.26 67.30 67.30 67.42 67.49 67.49 67.69 67.73 67.73
Public 32.74 32.70 32.70 32.58 32.51 32.51 32.31 32.27 32.27
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Bajaj Healthcare Ltd. Announcements

View details >>
Wed, 24 Apr 2024
Disclosure under SEBI Takeover Regulations
Sajankumar R. Bajajￂﾠhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of Indiaￂﾠ(Substantial Acquisition of Shares and Takeovers) Regulations, 2011.ￂﾠ
Fri, 12 Apr 2024
Spurt in Volume
Significant increase in volume has been observed in Bajaj Healthcare Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.
Thu, 28 Mar 2024
Trading Window-XBRL
Bajaj Healthcare Limited has informed the Exchange about Closure of Trading Window

Bajaj Healthcare Ltd. Technical Scans

View details >>
Thu, 25 Apr 2024
High Increase in 1 Month High Increase in 1 Month
High Decrease in 6 Months High Decrease in 6 Months
MFI Bearish MFI Bearish
CCI Overbought Zone CCI Overbought Zone
Close Above Last Week High Close Above Last Week High

Bajaj Healthcare Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 364,830.88 1,520.15 +2.3%
Cipla Ltd. 113,471.29 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. 103,713.42 6,218.75 +4.5%
Divi's Laboratories Ltd. 101,959.84 3,843.80 +0.8%
Zydus Lifesciences Ltd. 95,944.41 951.25 +1.9%
Mankind Pharma Ltd. 95,926.91 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. 91,425.47 6,384.10 +1.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.96 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-12 30.60 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.84 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-12 73.73 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.26 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-12 55.54 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 115.83 6,384.10 +1.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.85 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-12 4.38 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.86 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-12 7.82 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.09 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-12 10.80 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.54 6,384.10 +1.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,384.10 +1.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,384.10 +1.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,384.10 +1.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,384.10 +1.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,384.10 +1.6%

Bajaj Healthcare Ltd. FAQ's

What is Bajaj Healthcare share price?
Can I buy Bajaj Healthcare shares now?
What is the Dividend Yield of Bajaj Healthcare?
What is the Market Cap of Bajaj Healthcare?
What are the key metrics to analyse Bajaj Healthcare?
What is the 52 Week High and Low of Bajaj Healthcare?
What is the trend of Bajaj Healthcare share price?